These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23635904)

  • 1. Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Hassani M; Swann E; Bibby JM; Beall HD; Moody CJ
    Bioorg Med Chem; 2013 Jun; 21(11):2999-3009. PubMed ID: 23635904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
    Colucci MA; Moody CJ; Couch GD
    Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
    Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
    Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
    J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.
    Colucci MA; Reigan P; Siegel D; Chilloux A; Ross D; Moody CJ
    J Med Chem; 2007 Nov; 50(23):5780-9. PubMed ID: 17944451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolequinone antitumor agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase. Part 2.
    Swann E; Barraja P; Oberlander AM; Gardipee WT; Hudnott AR; Beall HD; Moody CJ
    J Med Chem; 2001 Sep; 44(20):3311-9. PubMed ID: 11563930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.
    Zhang K; Chen D; Ma K; Wu X; Hao H; Jiang S
    J Med Chem; 2018 Aug; 61(16):6983-7003. PubMed ID: 29712428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolequinone antitumour agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.
    Newsome JJ; Swann E; Hassani M; Bray KC; Slawin AM; Beall HD; Moody CJ
    Org Biomol Chem; 2007 May; 5(10):1629-40. PubMed ID: 17571194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues.
    Chen L; Xie YZ; Luo ZY; Liu LJ; Zou ZZ; Liu HD; Kong FR; Hao Y; Gao JL; Wang LL; Ma DY; Liu SY
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127286. PubMed ID: 32631508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6-arylamino-5,8-quinolinediones and 6-chloro-7-arylamino-5,8-isoquinolinediones on NAD(P)H: quinone oxidoreductase (NQO1) activity and their cytotoxic potential.
    Ryu CK; Jeong HJ; Lee SK; You HJ; Choi KU; Shim JY; Heo YH; Lee CO
    Arch Pharm Res; 2001 Oct; 24(5):390-6. PubMed ID: 11693537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
    Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
    Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betulin-1,4-quinone hybrids: Synthesis, anticancer activity and molecular docking study with NQO1 enzyme.
    Kadela-Tomanek M; Bębenek E; Chrobak E; Marciniec K; Latocha M; Kuśmierz D; Jastrzębska M; Boryczka S
    Eur J Med Chem; 2019 Sep; 177():302-315. PubMed ID: 31158746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic Cytotoxicity of Aromatic
    Nemeikaitė-Čėnienė A; Šarlauskas J; Misevičienė L; Marozienė A; Jonušienė V; Lesanavičius M; Čėnas N
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates.
    Fagan V; Bonham S; Carty MP; Saenz-Méndez P; Eriksson LA; Aldabbagh F
    Bioorg Med Chem; 2012 May; 20(10):3223-32. PubMed ID: 22522008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-electron reduction of quinones by rat liver NAD(P)H:quinone oxidoreductase: quantitative structure-activity relationships.
    Anusevicius Z; Sarlauskas J; Cenas N
    Arch Biochem Biophys; 2002 Aug; 404(2):254-62. PubMed ID: 12147263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones.
    Gaikwad NW; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2007 Nov; 43(9):1289-98. PubMed ID: 17893042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.